The joys of optometry learning, virtually

Optometry Australia hosted its 2021 instalment of Optometry Virtually Connected (OVC) at the end of June, with more than 2,400 delegates logging in. As...

Covid and can-do Dos

Along with everyone else, more than a year ago now, New Zealand’s optometry practices were thrown into turmoil amid a nationwide lockdown. Returning to...

The impact of diet on glaucoma

While drop therapies and surgical intervention are commonly used to control elevated intraocular pressure (IOP) associated with glaucoma, alternative health...

Glaucoma: take it or leaf it?

In 1976, Robert Randall took on the United States government and won. Diagnosed with glaucoma and having tried conventional medication, the only treatment...

Dispensing Matters: Helping low vision patients

Historically, referrals to Blind Low Vision New Zealand (BLVNZ) have mainly been made by ophthalmologists and optometrists when a patient’s vision reached...

OTC focuses on glaucoma

This year’s Ocular Therapeutics Conference has been divided into four ocular therapeutics evenings (OTEs) due to potential pandemic-related interruptions....

SPONSORED: The new CT Lucia IOL from Zeiss

The ZEISS CT LUCIA 621P/PY is a new generation of aspheric, monofocal, hydrophobic C-loop intraocular lens (IOL) featuring the patented ZEISS Optic (ZO)...

Diagnosis and management of macular polypoidal choroidal vasculopathy

Polypoidal choroidal vasculopathy (PCV) has historically been considered a subtype of neovascular age-related macular degeneration (nAMD). It is characterised...

Getting to grips with glaucoma

It was a case of third time lucky for the 2021 Glaucoma New Zealand (GNZ) Symposium. After two postponements over the past year, the symposium successfully...

You count your blessings

I have been in hospital. I have been counting my blessings, thankful to be in the hands of people who know what to do when things go wrong. I have been...

Stars and their eyes… Steve Bate

Double-Paralympic champion Steve Bate was diagnosed with retinitis pigmentosa (RP) in 2011 and is officially blind, with about 10% of his vision remaining....

Central serous chorioretinopathy cases

Central serous chorioretinopathy (CSCR) is the fourth most common retinal disease¹. But unlike other common retinal diseases, CSCR commonly affects working-age...

347 articles found

Bottom Banner Advert